RANCHO CORDOVA, Calif., Sept. 7, 2021 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO) a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that Chris Xu, Ph.D., Chief Executive Officer, will present a company overview at the H.C. Wainwright 23rd Annual Global Investment Conference.

If you are an institutional investor and would like to listen to the company's on-demand presentation, please click on the following link to register for the conference: www.hcwevents.com. Once your registration is confirmed, you will be prompted to log into the conference website to request a one-on-one meeting with the company.

About ThermoGenesis Holdings, Inc.
ThermoGenesis Holdings, Inc. develops, commercializes, and markets a range of automated technologies for CAR-T and other cell-based therapies. The Company currently markets a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally-closed CAR-TXpress™ platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market. For more information about ThermoGenesis, please visit: www.thermogenesis.com.

Company Contact: 
Wendy Samford
916-858-5191
ir@ThermoGenesis.com

Investor Contact: 
Paula Schwartz, Rx Communications
917-322-2216
pschwartz@rxir.com

 

Cision View original content:https://www.prnewswire.com/news-releases/thermogenesis-holdings-to-participate-in-the-hc-wainwright-23rd-annual-global-investment-conference-301369008.html

SOURCE ThermoGenesis Holdings, Inc.

Copyright 2021 PR Newswire

ThermoGenesis (NASDAQ:THMO)
Historical Stock Chart
From Sep 2021 to Oct 2021 Click Here for more ThermoGenesis Charts.
ThermoGenesis (NASDAQ:THMO)
Historical Stock Chart
From Oct 2020 to Oct 2021 Click Here for more ThermoGenesis Charts.